v3.26.1
Condensed Consolidated Statements of Equity (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings (Accumulated Deficit) [Member]
Balance at Dec. 31, 2024 $ 3,073,715 $ 918 $ 2,685,464 $ 387,333
Balance, Shares at Dec. 31, 2024   91,775    
Common stock issued under stock incentive plans   $ 2 (2)  
Common stock issued under stock incentive plans, shares   217    
Repurchase of shares for payroll tax withholding, net of proceeds from stock option exercises (1,936)   (1,936)  
Repurchase of common stock, including excise tax (47,272) $ (16)   (47,256)
Repurchase of common stock, including excise tax, shares   (1,603)    
Equity-based compensation expense 8,677   8,677  
Net income attributable to Acadia Healthcare Company, Inc. 8,374     8,374
Balance at Mar. 31, 2025 3,041,558 $ 904 2,692,203 348,451
Balance, Shares at Mar. 31, 2025   90,389    
Balance at Dec. 31, 2024 3,073,715 $ 918 2,685,464 387,333
Balance, Shares at Dec. 31, 2024   91,775    
Repurchase of common stock, including excise tax (50,400)      
Net income attributable to Acadia Healthcare Company, Inc. 38,501      
Balance at Jun. 30, 2025 3,077,986 $ 904 2,701,663 375,419
Balance, Shares at Jun. 30, 2025   90,394    
Balance at Mar. 31, 2025 3,041,558 $ 904 2,692,203 348,451
Balance, Shares at Mar. 31, 2025   90,389    
Common stock issued under stock incentive plans   $ 1 (1)  
Common stock issued under stock incentive plans, shares   109    
Repurchase of shares for payroll tax withholding, net of proceeds from stock option exercises (1,780)   (1,780)  
Repurchase of common stock, including excise tax (3,160) $ (1)   (3,159)
Repurchase of common stock, including excise tax, shares   (104)    
Equity-based compensation expense 10,549   10,549  
Other 692   692  
Net income attributable to Acadia Healthcare Company, Inc. 30,127     30,127
Balance at Jun. 30, 2025 3,077,986 $ 904 2,701,663 375,419
Balance, Shares at Jun. 30, 2025   90,394    
Common stock issued under stock incentive plans, shares   38    
Repurchase of shares for payroll tax withholding, net of proceeds from stock option exercises (237)   (237)  
Repurchase of common stock, including excise tax 9     9
Equity-based compensation expense 6,031   6,031  
Other 262   262  
Net income attributable to Acadia Healthcare Company, Inc. 36,246     36,246
Balance at Sep. 30, 2025 3,120,297 $ 904 2,707,719 411,674
Balance, Shares at Sep. 30, 2025   90,432    
Common stock issued under stock incentive plans   $ 1 (1)  
Common stock issued under stock incentive plans, shares   21    
Repurchase of shares for payroll tax withholding, net of proceeds from stock option exercises (273)   (273)  
Repurchase of common stock, including excise tax 4     4
Equity-based compensation expense 6,451   6,451  
Net income attributable to Acadia Healthcare Company, Inc. (1,177,519)     (1,177,519)
Balance at Dec. 31, 2025 1,948,960 $ 905 2,713,896 (765,841)
Balance, Shares at Dec. 31, 2025   90,453    
Common stock issued under stock incentive plans   $ 3 (3)  
Common stock issued under stock incentive plans, shares   311    
Repurchase of shares for payroll tax withholding, net of proceeds from stock option exercises (2,744)   (2,744)  
Equity-based compensation expense 7,956   7,956  
Net income attributable to Acadia Healthcare Company, Inc. 4,105     4,105
Balance at Mar. 31, 2026 1,958,277 $ 908 2,719,105 (761,736)
Balance, Shares at Mar. 31, 2026   90,764    
Balance at Dec. 31, 2025 1,948,960 $ 905 2,713,896 (765,841)
Balance, Shares at Dec. 31, 2025   90,453    
Net income attributable to Acadia Healthcare Company, Inc. 15,033      
Balance at Jun. 30, 2026 1,979,122 $ 909 2,729,021 (750,808)
Balance, Shares at Jun. 30, 2026   90,868    
Balance at Mar. 31, 2026 1,958,277 $ 908 2,719,105 (761,736)
Balance, Shares at Mar. 31, 2026   90,764    
Common stock issued under stock incentive plans   $ 1 (1)  
Common stock issued under stock incentive plans, shares   104    
Repurchase of shares for payroll tax withholding, net of proceeds from stock option exercises (1,063)   (1,063)  
Equity-based compensation expense 10,990   10,990  
Other (10)   (10)  
Net income attributable to Acadia Healthcare Company, Inc. 10,928     10,928
Balance at Jun. 30, 2026 $ 1,979,122 $ 909 $ 2,729,021 $ (750,808)
Balance, Shares at Jun. 30, 2026   90,868